157 related articles for article (PubMed ID: 8440559)
1. Treatment of paucibacillary leprosy.
Saxena U; Misra RS; Ramesh V
Int J Dermatol; 1993 Feb; 32(2):135-7. PubMed ID: 8440559
[TBL] [Abstract][Full Text] [Related]
2. Clinical assessment of paucibacillary leprosy under multidrug therapy-three years followup study.
Revankar CR; Karjivkar VG; Gurav VJ; Ganapati R
Indian J Lepr; 1989 Jul; 61(3):355-9. PubMed ID: 2768883
[TBL] [Abstract][Full Text] [Related]
3. Relapses in paucibacillary leprosy after MDT--a clinical study.
Grugni A; Nadkarni NJ; Kini MS; Mehta VR
Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185
[TBL] [Abstract][Full Text] [Related]
4. Four-year follow-up results of a WHO-recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi.
Boerrigter G; Pönnighaus JM; Fine PE; Wilson RJ
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):255-61. PubMed ID: 2071983
[TBL] [Abstract][Full Text] [Related]
5. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy trial in paucibacillary leprosy using clofazimine.
Katoch K; Natarajan M; Katoch VM; Singh HB; Bhatia AS
Indian J Lepr; 1999; 71(3):311-24. PubMed ID: 10626237
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic prospects for paucibacillary leprosy.
Katoch K
Indian J Lepr; 2000; 72(3):351-61. PubMed ID: 11105276
[No Abstract] [Full Text] [Related]
8. Leprosy - an overview of clinical features, diagnosis, and treatment.
Fischer M
J Dtsch Dermatol Ges; 2017 Aug; 15(8):801-827. PubMed ID: 28763601
[TBL] [Abstract][Full Text] [Related]
9. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281
[TBL] [Abstract][Full Text] [Related]
10. Relapse in a borderline-tuberculoid case of leprosy 5 years after the release from rifampicin monotherapy.
Shetty VP; Antia NH
Lepr Rev; 1997 Jun; 68(2):162-6. PubMed ID: 9217356
[No Abstract] [Full Text] [Related]
11. Ulnar abscess: 4 months after release from control with paucibacillary-multidrug therapy.
Darius EJ; Selvasekar A; Mani MN; Jesudasan K
Lepr Rev; 1997 Jun; 68(2):173-4. PubMed ID: 9217358
[No Abstract] [Full Text] [Related]
12. Clinical and histopathological activity in paucibacillary leprosy patients after fixed-duration multidrug therapy.
Ebenezer GJ; Suneetha S; Arunthathi S
Lepr Rev; 1997 Sep; 68(3):218-24. PubMed ID: 9364822
[TBL] [Abstract][Full Text] [Related]
13. Problems of multidrug therapy.
Ramu G
Indian J Lepr; 1991; 63(3-4):435-45. PubMed ID: 1804896
[No Abstract] [Full Text] [Related]
14. Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
Sehgal VN; Kumar S; Jain S; Bhattacharya SN
J Dermatol; 1998 Jan; 25(1):63-5. PubMed ID: 9519615
[No Abstract] [Full Text] [Related]
15. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
Young RJ; Gilson RT; Elston DM
Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
[TBL] [Abstract][Full Text] [Related]
16. Bigger may not always be better: giant borderline tuberculoid leprosy lesion.
Ghorpade A
Lepr Rev; 2005 Jun; 76(2):182-3. PubMed ID: 16038255
[No Abstract] [Full Text] [Related]
17. Occurrence and management of leprosy reaction in China in 2005.
Shen J; Liu M; Zhou M; Wengzhong L
Lepr Rev; 2009 Jun; 80(2):164-9. PubMed ID: 19743620
[TBL] [Abstract][Full Text] [Related]
18. Allocation of patients to paucibacillary or multibacillary drug regimens for the treatment of leprosy--a comparison of methods based mainly on skin smears as opposed to clinical methods--alternative clinical methods for classification of patients.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):292-303. PubMed ID: 2071986
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing between relapse and late reversal reaction in multidrug (MDT)-treated BT leprosy.
Waters MF
Lepr Rev; 2001 Sep; 72(3):250-3. PubMed ID: 11715270
[No Abstract] [Full Text] [Related]
20. A study of relapse in paucibacillary leprosy in a multidrug therapy project, Baroda District, India.
Chopra NK; Agarawal JS; Pandya PG
Lepr Rev; 1990 Jun; 61(2):157-62. PubMed ID: 2198415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
